I got a chance to check it out at a preview event, and I was intrigued. (Unfortunately, I was also clean-shaven, so while I ...

BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...